2020
DOI: 10.24095/hpcdp.40.5/6.01
|View full text |Cite
|
Sign up to set email alerts
|

Problematic substance use or problematic substance use policies?

Abstract: This special issue on substance use issues comes at a critical time for Canadian health policy makers and researchers. Most attention is currently focussed on the opioid crisis and the potential impacts of cannabis legalization. However, our most widely used and harmful substances continue to be alcohol and nicotine. Our policies to reduce harms from these substances are failing. While alcohol control policies are being gradually abandoned, opportunities to maximize the harm reduction potential of new, alterna… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 17 publications
(17 reference statements)
0
1
0
Order By: Relevance
“…Neurologically, MAT may induce persistent changes that compromise endorphin, dopamine, and multiple brain systems. While chronic use of agonist therapies may be necessary in the absence of other options, there is limited data on chronic vs. acute use harm reduction [ 11 , 12 ]. However, there is evidence that treatments themselves, like long-term agonist treatments for opioid use disorder (OUD), may also cause Reward Deficiency Syndrome (RDS) [ 13 ], which is a breakdown of reward neurotransmission that causes a broad range of addictive, impulsive, and compulsive behaviors.…”
Section: Introductionmentioning
confidence: 99%
“…Neurologically, MAT may induce persistent changes that compromise endorphin, dopamine, and multiple brain systems. While chronic use of agonist therapies may be necessary in the absence of other options, there is limited data on chronic vs. acute use harm reduction [ 11 , 12 ]. However, there is evidence that treatments themselves, like long-term agonist treatments for opioid use disorder (OUD), may also cause Reward Deficiency Syndrome (RDS) [ 13 ], which is a breakdown of reward neurotransmission that causes a broad range of addictive, impulsive, and compulsive behaviors.…”
Section: Introductionmentioning
confidence: 99%